… to individuals with the wild type CYP gene (CYP2C9*1). There are … in NSAID treated patients
with genetic polymorphism. In this review, complications associated with the use of NSAIDs …

… three major drug groups used for pain treatment (ie, NSAIDs, TCAs, SSRIs that fulfilled …
genetic variation in CYP2C9 and CYP2C8 only have a very modest influence on the ibuprofen …

… efficacy of nonsteroidal anti-inflammatory drugs and selective … genetic variations to predict
patient risk and benefit to drugs. … from ibuprofen (P = .001) and rofecoxib (P = .049) treatment …

… to NSAIDs, reflecting the complex interplay between mechanisms of pain, differences between
distinct NSAIDs, and patient-specific factors such as genetic variation… to NSAID treatment. …

… Better understanding of the role of COX-2 genetic variation and interaction with NSAID use
… Although few have reported on interaction of COX-2 variation with individual NSAIDs, our …

… gene approach with the aim of assessing the association of the complex genetic variation
within UGT1A and UGT2B gene … risk and effect modification of NSAID use on colorectal cancer. …

… nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). ASA and other NSAIDs exert
some … the role of genetic variation in COX-1 relative to the function of the gene by measuring …

… Celecoxib, a type of NSAID designed for COX-2 inhibition that is used clinically to treat …
COX-2 with tumorigenesis are not predictable, the genetic variations in COX-2 are a remarkable …

… treatment endodontic pain remains unknown. Animal studies indicate that genetic variations
… may ultimately improve the safe and effective use of NSAIDS by better tailoring drug dosage …

… Tramadol (TRA) and ibuprofen (IBU) belong to opioid and nonsteroidal anti-inflammatory
drug (NSAID) families, respectively, which are widely used for the treatment of pain in clinical …